Amal Rayan

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Topics

Squamous Cell Carcinoma

Locally Advanced

Top Venues

International journal of general medicine

Cancer management and research

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Heba Ahmed Osman, Hanaa Nafady-Hego, Khalid Ali Nasif, Heba A Ahmed, Ekram Abdel-Rahman Mahmoud, Noher Mohamad Abass, Amal Rayan, Marwa Ahmed Mahmoud, Asmaa Nafady
Peripheral Mononuclear Cells Surface Markers Evaluation in Different Stages of Hepatocellular Carcinoma; in a Trial for Early and Accurate Diagnosis in Patients with Post-Hepatitis Liver Cirrhosis and Unremarkable Raised AFP. International journal of general medicine 16 (2023)
Amal Rayan, Ahmed Soliman
Applying a neoscore in locally advanced rectal cancer is beneficial in predicting local recurrences after surgery. PloS one 18 (5) (2023)
Amal Rayan, Ahmed Soliman
Applying a neoscore in locally advanced rectal cancer is beneficial in predicting local recurrences after surgery. PloS one 18 (5) (2023)
Amal Rayan, Ahmed Soliman
Applying a neoscore in locally advanced rectal cancer is beneficial in predicting local recurrences after surgery. PloS one 18 (5) (2023)
Heba Ahmed Osman, Hanaa Nafady-Hego, Khalid Ali Nasif, Heba A Ahmed, Ekram Abdel-Rahman Mahmoud, Noher Mohamad Abass, Amal Rayan, Marwa Ahmed Mahmoud, Asmaa Nafady
Peripheral Mononuclear Cells Surface Markers Evaluation in Different Stages of Hepatocellular Carcinoma; in a Trial for Early and Accurate Diagnosis in Patients with Post-Hepatitis Liver Cirrhosis and Unremarkable Raised AFP. International journal of general medicine 16 (2023)
Asmaa M Zahran, Amal Rayan, Zeinab Albadry M Zahran, Wael M Y Mohamed, Dalia O Mohamed, Mona H Abdel-Rahim, Omnia El-Badawy
Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer. PloS one 17 (1) (2022)
Asmaa M Zahran, Omnia El-Badawy, Lamiaa M Kamel, Amal Rayan, Khalid Rezk, Mona H Abdel-Rahim
Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Can Boost Immune Disruption. Cancer management and research 13 (2021)
Asmaa M Zahran, Omnia El-Badawy, Wageeh A Ali, Zainab Gaber Mahran, Essam Eldeen M O Mahran, Amal Rayan
Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID-19; relation to cancer. PloS one 16 (2) (2021)
Asmaa M Zahran, Omnia El-Badawy, Khalid I Elsayh, Wael M Y Mohamed, Khalid F Riad, Mona H Abdel-Rahim, Amal Rayan
Upregulation of CD146 in Pediatric B-Cell Acute Lymphocytic Leukemia and Its Implications on Treatment Outcomes. Journal of immunology research 2020 (2020)
Asmaa H M Soliman, Nasef N Zaki, Hala M Fathy, Aml A Mohamed, Mohamed A Ezzat, Amal Rayan
Genetic polymorphisms in XRCC1, OGG1, and XRCC3 DNA repair genes and DNA damage in radiotherapy workers. Environmental science and pollution research international 27 (35) (2020)
Asmaa M Zahran, Sawsan M Moeen, Ahmad F Thabet, Amal Rayan, Mona Hussein Abdel-Rahim, Wael M Y Mohamed, Helal F Hetta
Monocytic myeloid-derived suppressor cells in chronic lymphocytic leukemia patients: a single center experience. Leukemia & lymphoma 61 (7) (2020)
Amal Rayan, Ola N Abdel Fattah, Ahmed Soliman, Hosam A Hasan, Asmaa M Zahran
Efficacy of Docetaxel and Oxaliplatin Regimen as a Second-Line Therapy for Patients with Advanced Pancreatic Adenocarcinoma. Journal of gastrointestinal cancer 50 (3) (2020)